QTc
Showing 1 - 25 of 1,793
QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)
Recruiting
- QT/QTc
- Ecopipam Hydrochloride
- +2 more
-
Austin, TexasPPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023
Influenza, Human Trial in Shanghai (ZX-7101A, Placebo)
Not yet recruiting
- Influenza, Human
- ZX-7101A
- Placebo
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Jul 20, 2023
Analgesia Trial in Erzurum (BMI=30; Combined Spinal Epidural Anesthesia, BMI:18,5-24,9; Combined Spinal Epidural Anesthesia)
Recruiting
- Analgesia
- BMI≥30; Combined Spinal Epidural Anesthesia
- BMI:18,5-24,9; Combined Spinal Epidural Anesthesia
-
Erzurum, TurkeyAtaturk University
Aug 29, 2023
Postpartum Hemorrhage Trial in Tempe (Carbetocin, Placebo, Placebo and Moxifloxacin)
Recruiting
- Postpartum Hemorrhage
- Carbetocin
- +2 more
-
Tempe, ArizonaFerring Investigational Site
Jun 20, 2023
Healthy Trial in New Haven (sisunatovir, , moxifloxacin)
Recruiting
- Healthy
- sisunatovir
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
May 18, 2023
Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Toshima-ku, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Castration-Resistant Prostate Cancer Trial (SHR3680 tablets)
Not yet recruiting
- Castration-Resistant Prostate Cancer
- SHR3680 tablets
- (no location specified)
Nov 1, 2022
Non-alcoholic Steatohepatitis Trial in Berlin (Cotadutide, Cotadutide-, Moxifloxacin)
Recruiting
- Non-alcoholic Steatohepatitis
- Cotadutide
- +3 more
-
Berlin, GermanyResearch Site
Jan 16, 2023
Health Adult Subjects Trial (Omaveloxolone, Moxifloxacin)
Not yet recruiting
- Health Adult Subjects
- (no location specified)
Jun 28, 2023
Healthy Subjects Trial in Phoenix (1.25 mg/kg BL-8040 + BL-8040-matching , 2 mg/kg BL-8040, BL-8040-matching )
Completed
- Healthy Subjects
- 1.25 mg/kg BL-8040 + BL-8040-matching placebo
- +3 more
-
Phoenix, ArizonaCelerion
Jan 1, 2023
HSV Infection Trial in London (Pritelivir and moxifloxacin , Pritelivir , moxifloxacin and moxifloxacin , Pritelivir ,
Recruiting
- HSV Infection
- Pritelivir and moxifloxacin placebo
- +2 more
-
London, United KingdomRichmond Pharmacology Ltd
Jan 3, 2023
Healthy Subjects Trial in Shanghai (TPN171H 10 mg Group, TPN171H 30 mg Group, TPN171H 40 mg Group)
Recruiting
- Healthy Subjects
- TPN171H 10 mg Group
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Feb 19, 2023
Tumor Trial (Tusamitamab ravtansine)
Not yet recruiting
- Neoplasm
- Tusamitamab ravtansine
- (no location specified)
Jun 22, 2022
Tumors, Cardiac Arrhythmia Trial in Parkville (ECG application, 12 lead ECG)
Not yet recruiting
- Neoplasms
- Cardiac Arrhythmia
- ECG application
- 12 lead ECG
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital
Dec 7, 2022
QTc Intervals in Former Preterm/Extreme Low Birth Weight
Enrolling by invitation
- Qt Interval
- Preterm Birth
- ECG (diagnostic)
-
Leuven, Belgium
- +1 more
Jul 7, 2022
Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)
Active, not recruiting
- Castration-Resistant Prostate Cancer
-
Greenville, South Carolina
- +4 more
Aug 2, 2022
Long QT Syndrome Trial in West Bend (LQT-1213, Placebo, Dofetilide 250 µg Cap)
Active, not recruiting
- Long QT Syndrome
- LQT-1213
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research, LLC
Jun 15, 2023